April 6, 2017 09:56 AM EDT
News Briefing

Adap­ti­m­mune rais­es $106M for pipeline work; Kalo­Bios chief says biotech is on track for Cha­gas drug fil­ing

Shehla Shakoor

Managing Director

→ Ma­trix Cap­i­tal Man­age­ment has scooped up $42 mil­lion worth of Adap­ti­m­mune stock $ADAP, pay­ing a slight pre­mi­um for the block of shares. We …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times